Dazadrol

This classification denotes an antidepressant agent with the molecular formula C15H14CLN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9U27285V5R chemically known as 2-pyridinemethanol, .alpha.-(4-chlorophenyl)-.alpha.-(4,5-dihydro-1h-imidazol-2-yl)- but generally known as dazadrol, which bears US NIH Compound Identifier 32940. European Medicines Agency schedules Dazadrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06918MIG. The term DAZADROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, no. 10 1973, list 13. ). Most nations schedule dazadrol under HS 29333999 and SITC 51574. As of Q4 2014, DAZADROL remains the US FDA Preferred Term for this commodity. Dazadrol bears US NLM identifiers UMLS ID C2827129 and NCI Concept Code C83654. SMILES: C1CN=C(N1)C(C2=CC=C(C=C2)Cl)(C3=CC=CC=N3)O.